Jens Schneider-Mergener
Nessuna posizione attualmente
Storia della carriera di Jens Schneider-Mergener
Precedenti posizioni note di Jens Schneider-Mergener
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Amministratore Delegato | 01/08/2019 | 01/01/2021 |
| PHARVARIS N.V. | Fondatore | 30/09/2015 | - |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Presidente | - | - |
Formazione di Jens Schneider-Mergener
| University of Bielefeld | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 5 |
| Paesi Bassi | 2 |
Posizioni
| Chairman | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Aziende private | 2 |
|---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
